Key facts
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2022, 16:41.
Jon Snodgres - 16 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RGEN
- Reported as of
- 16 Aug 2022
- Net transaction value
- -$1,222,229
- SEC form
- 4
- Accepted by SEC
- 17 Aug 2022, 16:41:45 UTC
- Prior SEC filing
- 02 Aug 2022
- Next SEC filing
- 11 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberly Brown (Attorney in Fact)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 17 Aug 2022.
Change
- Previous filing in this sequence was filed on 02 Aug 2022.
- Current net transaction value: -$1,222,229.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $262,347
- Shares
- +3,047
- Change %
- +8.2%
- Price
- $86.10
- Shares after
- 40,234
- Date
- 16 Aug 2022
- Ownership
- Direct
RGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $209,113
- Shares
- +970
- Change %
- +2.4%
- Price
- $215.58
- Shares after
- 41,204
- Date
- 16 Aug 2022
- Ownership
- Direct
RGEN
transaction
Common Stock
Sale
- Transaction value
- $1,086,105
- Shares
- -4,298
- Change %
- -10%
- Price
- $252.70
- Shares after
- 36,906
- Date
- 16 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
RGEN
transaction
Common Stock
Sale
- Transaction value
- $607,584
- Shares
- -2,400
- Change %
- -6.5%
- Price
- $253.16
- Shares after
- 34,506
- Date
- 16 Aug 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RGEN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- +3,047
- Change %
- Price
- $0.000000
- Shares after
- 1,524
- Date
- 16 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,047
- Exercise price
- $86.10
- Footnotes
- F2
RGEN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- +970
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 1,940
- Date
- 16 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 970
- Exercise price
- $215.58
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
$252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F2
1,524 shares vest and become exercisable on 2/27/2023.
Footnote F3
Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.